Home/Smart Money/B Group, Inc.
§ 13F · FUND PROFILE

B Group, Inc..

AUM · $105M (13F)Positions · 17Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$52M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS

The book · Q2 2026

FILED AUG 14, 2026
#TickerNameShares$ value% portΔ Q2
1QQQINVESCO QQQ TR50K$37M17.3%NEW
2ADMAADMA BIOLOGICS INC3.26M$27M12.8%+2%
3PALIPALISADE BIO INC11.41M$24M11.2%±0%
4NRXPNRX PHARMACEUTICALS INC4.09M$17M7.9%+36%
5SNSEFAETH THERAPEUTICS INC610K$15M7.2%NEW
6TSHATAYSHA GENE THERAPIES INC1.80M$12M5.8%±0%
7PRAXPRAXIS PRECISION MEDICINES I33K$11M5.2%±0%
8CLLSCELLECTIS S A3.28M$10M4.6%±0%
9ZLABZAI LAB LTD451K$9M4.0%±0%
10GPCRSTRUCTURE THERAPEUTICS INC140K$8M3.5%+10%
§ 02 · SECTOR ALLOCATION

Where the money is

Sector data pending
§ 03 · THE B SIGNAL

AC read

B Group, Inc. is a Other fund managing $105 million in assets. The fund runs a focused portfolio of just 17 positions.

Read the full dossier →